Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect on Glycemic Control of Liraglutide in Combination With Rosiglitazone Plus Metformin Versus Rosiglitazone Plus Metformin in Subjects With Type 2 Diabetes

NCT00333151 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00333151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00333151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect on Glycemic Control of Liraglutide in Combination With Rosiglitazone Plus Metformin Versus Rosiglitazone Plus Metformin in Subjects With Type 2 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
August 31, 2007
Enrollment
576 (actual)
Sites
89

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2